Health Trials

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

ConditionMesothelioma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDana-Farber Cancer Institute

About this trial

This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.

Eligibility criteria

Qualifiers

All adult patients with a diagnosis of malignant pleural mesothelioma undergoing

diagnostic pleural biopsy

pleuroscopy

and/or VATS resections

Disqualifiers

surgery,

treatment

diagnosis,

Trial design

Treatments tested in this trial

  • MPT Test
  • CLDN15/VIM Test

Treatment groups

240 Participants
are divided into 1 treatment group

Sponsors and collaborators

Dana-Farber Cancer Institute

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov